On Feb. 5, cardiovascular treatment company Edwards Lifesciences (NYSE:EW) released fourth-quarter earnings for the period ended Dec. 31.
- Fourth-quarter net sales increased by 6.4% compared to the same quarter last year, mainly because of low double-digit growth out of the company's critical care segment.
- The company plans to achieve sales near $1.1 billion and earnings per share in the range of $0.55 to $0.57 for fiscal 2007.
- Edwards Lifesciences has a lowly two-star rating in CAPS, the Fool's stock-rating service.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Q4 2006 |
Q4 2005 |
Change | |
|---|---|---|---|
|
Sales |
$265.6 |
$249.7 |
6.4% |
|
Net Profit |
$20.7 |
$38.6 |
(46.4%) |
|
EPS |
$0.34 |
$0.61 |
(44.3%) |
|
Diluted Shares |
60.4 |
64.9 |
(6.9%) |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q4 2006 |
Q4 2005 |
Change* | |
|---|---|---|---|
|
Gross Margin |
63.3% |
64.1% |
(0.8) |
|
Operating Margin |
9.1% |
18.0% |
(8.9) |
|
Net Margin |
7.8% |
15.5% |
(7.7) |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
|
Assets |
Q4 2006 |
Q4 2005 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$182.8 |
$178.6 |
2.4% |
|
Accounts Rec. |
$127.1 |
$118.5 |
7.3% |
|
Inventory |
$142.1 |
$131.5 |
8.1% |
|
Liabilities |
Q4 2006 |
Q4 2005 |
Change |
|---|---|---|---|
|
Accounts Payable* |
$226.2 |
$194.2 |
16.5% |
|
Long-Term Debt |
$235.9 |
$316.1 |
(25.4%) |
Learn the ways of the balance sheet.
Cash Flow Highlights
|
Q4 2006 |
Q4 2005 |
Change | |
|---|---|---|---|
|
Cash From Ops. |
$70.0 |
$44.3 |
58.0% |
|
Capital Expenditures |
$17.4 |
$21.9 |
(20.5%) |
|
Free Cash Flow |
$52.6 |
$22.4 |
134.8% |
Find out why Fools always follow the money.
Related Companies:
- Intuitive Surgical (NASDAQ:ISRG)
- Kinetic Concepts (NYSE:KCI)
- Respironics (NASDAQ:RESP)
- Hologic (NASDAQ:HOLX)
- Sirona Dental Systems (NASDAQ:SIRO)
Related Foolishness:
Intuitive Surgical is a Motley Fool Rule Breakers recommendation. To find out why, you can take a 30-day free trial of the growth-stock newsletter.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
